Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1121-1122

Elsevier

Access to resources Recommend Favorite

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1086-1093

Elsevier

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

By Kelly E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1105-1107

Elsevier

Access to resources Recommend Favorite

Transvaginal ovarian drilling: A new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome

By Ferraretti A.P.   Gianaroli L.   Magli M.C.   Iammarrone E.   Feliciani E.   Fortini D.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 812-816

Elsevier

Access to resources Recommend Favorite

Pregnancy loss following treatment with assisted reproductive technologies

By Mansour Fady W   Buckett William M  

Expert Review of Obstretrics and Gynecology, Vol. 3, Iss. 6, 2008-11 ,pp. : 767-774

Informa Healthcare

Access to resources Recommend Favorite